| BCBS Florida Coverage Guidelines | Onasemnogene abeparvovec (Zolgensma, (09-J3000-30) | 2026-07-15 |
| BCBS Florida Coverage Guidelines | Oral Therapy for Gaucher and Pompe (09-J0000-76) | 2026-07-15 |
| BCBS Florida Coverage Guidelines | Pasireotide (Signifor®, Signifor LAR®) (09-J1000-94) | 2026-07-15 |
| BCBS Florida Coverage Guidelines | Peanut (Arachis hypogaea) Allergen Powder- (09-J3000-69) | 2026-07-15 |
| BCBS Florida Coverage Guidelines | Psoralens Plus Ultraviolet A (PUVA) Therapy (02-10000-16) | 2026-07-15 |
| BCBS Florida Coverage Guidelines | Sacral Nerve Neuromodulation/Stimulation (02-61000-23) | 2026-07-15 |
| BCBS Florida Coverage Guidelines | Step Therapy Requirements for Medicare (09-J3000-39) | 2026-07-15 |
| BCBS Florida Coverage Guidelines | Surgical Treatment of Occipital Neuralgia and (02-20000-41) | 2026-07-15 |
| BCBS Florida Coverage Guidelines | Tafasitamab-cxix (Monjuvi®) IV Infusion (09-J3000-81) | 2026-07-15 |
| BCBS Florida Coverage Guidelines | Talquetamab-tgvs (Talvey) Subcutaneous (09-J4000-63) | 2026-07-15 |